Protein Z, a protein seeking a pathology

Thrombosis and Haemostasis

Volumn 100, Issue 4, 2008, Pages 548-556

  Vasse, Marc ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Arterial thrombosis; Coagulation inhibitors; Pregnancy; Vitamin K dependent factors

Indexed keywords

FATTY ACID BINDING PROTEIN; PHOSPHOLIPID ANTIBODY;

ARTERY DISEASE; ARTERY THROMBOSIS; BLEEDING; CHRONIC KIDNEY DISEASE; FETUS DEATH; GLOMERULONEPHRITIS; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HUMAN; ISCHEMIA; LIVER DISEASE; NEPHROTIC SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN Z DEFICIENCY; REVIEW; RISK FACTOR; STROKE; THALASSEMIA; VEIN THROMBOSIS;

ANIMALS; BLOOD COAGULATION DISORDERS; BLOOD PROTEINS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; VITAMIN K;

EID: 54949142813     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-01-0024     Document Type: Review

References (98)

1. Rau JC, Beaulieu LM, Huntington JA, et al. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 2007; 5: 102-115.
2. Han X, Fiehler R, Broze GJ Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA 1998; 95: 9250-9255.
3. Han X, Huang ZF, Fiehler R, et al. The protein Z-dependent protease inhibitor is a serpin. Biochemistry 1999; 38: 11073-11078.
4. Han X, Fiehler R, Broze GJ Jr. Characterization of the protein Z-dependent protease inhibitor. Blood 2000; 96: 3049-3055.
5. Prowse CV, Esnouf MP. The isolation of a new warfarin-sensitive protein from bovine plasma. Biochem Soc Trans 1977; 5: 255-256.
6. Broze GJ Jr, Miletich JP. Human protein Z. J Clin Invest 1984; 73: 933-938.
7. Petersen TE, Thlgersen HC, Sottrup-Jensen L, et al. Isolation and N-terminal amino acid sequence of protein Z, a gamma-carboxyglutamic acid containing protein from bovine plasma. FEBS Lett 1980; 114: 278-282.
8. Højrup P, Roepstorff P, Petersen TE. Amino-acid sequence of the vitamin-K-dependent part of protein Z. Eur J Biochem 1982; 126: 343-348.
9. Broze GJ Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost 2001; 86: 8-13.
10. Højrup P, Jensen MS, Petersen TE. Amino acid sequence of bovine protein Z: a vitamin K-dependent serine protease homolog. FEBS Lett 1985; 184: 333-338.
11. 2+ binding properties of the gamma-carboxyglutamic acid-containing module of protein Z in the intact protein and in N-terminal fragments. FEBS Lett 1992; 314: 5-9.
12. Fernlund P, Stenflo J. Beta-hydroxyaspartic acid in vitamin K-dependent proteins. J Biol Chem 1983; 258: 12509-1212.
13. Nishimura H, Kawabata S, Kisiel W, et al. Identification of a disaccharide (Xyl-Glc) and a trisaccharide (Xyl2-Glc) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z. J Biol Chem 1989; 264: 20320-20325.
14. Handford PA, Baron M, Mayhew M, et al. The first EGF-like domain from human factor IX contains a high-affinity calcium binding site. EMBO J 1990; 9: 475-480.
15. Morita T, Kaetsu H, Mizuguchi J, et al. A characteristic property of vitamin K-dependent plasma protein Z. J Biochem. 1988; 104: 368-374.
16. McDonald JF, Shah AM, Schwalbe RA, et al. Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site. Biochemistry 1997; 36: 5120-5127.
17. Miletich JP, Broze GJ Jr. Human plasma protein Z antigen: range in normal subjects and effect of warfarine therapy. Blood 1987; 69: 1580-1586.
18. Sejima H, Hayashi T, Deyashiki Y, et al. Primary structure of vitamin K-dependent human protein Z. Biochem Biophys Res Commun 1990; 171: 661-668.
19. Ichinose A, Takeya H, Espling E, et al. Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein. Biochem Biophys Res Commun 1990; 172: 1139-1144.
20. Iwanaga S, Nishimura H, Kawabata S, et al. A new trisaccharide sugar chain linked to a serine residue in the first EGF-like domain of clotting factors VII and IX and protein Z. Adv Exp Med Biol 1990; 281: 121-131.
21. Hogg PJ, Stenflo J. Interaction of vitamin K-dependent protein Z with thrombin. Consequences for the amidolytic activity of thrombin and the interaction of thrombin with phospholipids vesicles. J Biol Chem 1991; 266: 10953-10958.
22. Hogg PJ, Stenflo J. Interaction of human protein Z with thrombin: evaluation of the species difference in the interaction between bovine and human protein Z and thrombin. Biochem Biophys Res Commun 1991; 178: 801-807.
23. Lee CJ, Chandrasekaran V, Duke RE, et al. A proposed structural model of human protein Z. J Thromb Haemost 2007; 5: 1558-1561.
24. Souri M, Koseki-Kuno S, Iwata H, et al. A naturally occurring E30Q mutation in the Gla domain of protein Z causes its impaired secretion and subsequent deficiency. Blood 2005; 105: 3149-3154.
25. Rice GI, Futers TS, Grant PJ. Identification of novel polymorphisms within the protein Z gene, haplotype distribution and linkage analysis. Thromb Haemost 2001; 85: 1123-1124.
26. Kemkes-Matthes B, Matthes KJ, Souri M, et al. R255h amino acid substitution of protein Z identified in patients with factor V Leiden mutation. Br J Haematol 2005; 128: 248-252.
27. Kemkes-Matthes B, Matthes KJ. Protein Z, a new haemostatic factor, in liver diseases. Haemostasis 1995; 25: 312-316.
28. Vasse M, Denoyelle C, Corbière C, et al. Human endothelial cells synthesize protein Z, but not the protein Z dependent inhibitor. Thromb Haemost 2006; 95: 519-523.
29. Fujimaki K, Yamazaki T, Taniwaki M, et al. The gene for human protein Z is localized to chromosome 13 at band q34 and is coded by eight regular exons and one alternative exon. Biochemistry 1998; 37: 6838-6846.
30. Sugawara H, Iwata H, Souri M, et al. Regulation of human protein Z gene expression by liver-enriched transcription factor HNF-4alpha and ubiquitous factor Sp1. J Thromb Haemost 2007; 5: 2250-2258.
31. Santacroce R, Cappucci F, Di Perna P, et al. Protein Z gene polymorphisms are associated with protein Z plasma levels. J Thromb Haemost 2004; 2: 1197-1199.
32. Santacroce R, Sarno M, Cappucci F, et al. Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost 2006; 4: 2417-2422.
33. Lichy C, Kropp S, Dong-Si T, et al. A common polymorphism of the protein Z gene is associated with protein Z plasma levels and with risk of cerebral ischemia in the young. Stroke 2004; 35: 40-45.
34. Staton J, Sayer M, Hankey GJ, et al.Protein Z gene polymorphisms, protein Z concentrations, and ischemic stroke. Stroke 2005; 36: 1123-1127.
35. Iwata H, Souri M, Kemkes-Matthes B, et al. An additional Glu30Lys substitution in the Gla domain of the protein Z gene is not a common polymorphism but a rare mutation, which would cause its deficiency. J Thromb Haemost 2005; 3: 2360-2361.
36. Yin Z-F, Huang ZF, Cui J, et al. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci USA 2000; 97: 6734-6738.
37. Tabatabai A, Fiehler R, Broze GJ Jr . Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost 2001; 85: 655-660.
38. McQuillan AM, Eikelboom JW, Hankey GJ, et al. Protein Z in ischemic stroke and its etiologic subtypes. Stroke 2003; 34: 2415-2419.
39. Steffano B, Forastiero R, Martinuzzo M, et al. Low plasma protein Z levels in patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 2001; 12: 411-412.
40. Heeb MJ, Paganini-Hill A, Griffin JH, et al. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis 2002; 29: 139-144.
41. Refaai MA, Ahn C, Lu L, et al. Protein Z and ZPI levels and cardiovascular events. J Thromb Haemost 2006; 4: 1628-1629.
42. Heeb MJ, Fisher M, Paganini-Hill A. Association of low protein Z levels with ischemic stroke in young women. Thromb Haemost 2007; 97: 495-496.
43. Ravi S, Mauron T, Lämmle B, et al. Protein Z in healthy human individuals and in patients with a bleeding tendency.Br J Haematol 1998; 102: 1219-1223.
44. Fedi S, Sofi F, Brogi D, et al. Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost 2003; 90: 1173-1178.
45. Yurdakök M, Gürakan B, Ozbag E, et al. Plasma protein Z levels in healthy newborn infants. Am J Hematol 1995; 48: 206-207.
46. Schettini F Jr, Laforgia N, Altomare M, et al. Plasma protein Z levels in healthy and high-risk newborn infants. Acta Paediatr 2004; 93: 654-657.
47. Yurdakök M, Yigit S, Aygön C, et al. Plasma protein Z levels in early respiratory distress syndrome. Am J Hematol 1997; 54: 171-172.
48. Quack Loetscher KC, Stiller R, Roos M, et al. Protein Z in normal pregnancy. Thromb Haemost 2005; 93: 706-709.
49. Ramsay JE, Stewart F, Friel H, et al. Protein Z in pregnancy: exaggerated rise in obese women. J Thromb Haemost 2005; 3: 2584-2586.
50. Paidas MJ, Ku DH, Lee MJ, et al. Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. J Thromb Haemost 2005; 3: 497-501.
51. Bretelle F, Arnoux D, Shojai R, et al. Protein Z in patients with pregnancy complications. Am J Obstet Gynecol 2005; 193: 1698-1702.
52. Kusanovic JP, Espinoza J, Romero R, et al. Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor. J Matern Fetal Neonatal Med 2007; 20: 453-463.
53. Al-Shanqeeti A, van Hylckama Vlieg A, Berntorp E, et al. Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis. Thromb Haemost 2005; 93: 411-413.
54. Undar L, Karadogan I, Oztürk F. Plasma protein Z levels inversely correlate with plasma interleukin-6 levels in patients with acute leukemia and non-Hodgkin's lymphoma. Thromb Res 1999; 94: 131-134.
55. Vasse M, Denoyelle C, Legrand E, et al. Weak regulation of protein Z biosynthesis by inflammatory cytokines. Thromb Haemost 2002; 87: 350-351.
56. Cesari F, Gori AM, Fedi S, et al. Modifications of protein Z and interleukin-6 during the acute phase of coronary artery disease. Blood Coagul Fibrinolysis 2007; 18: 85-86.
57. Ozkaya O, Bek K, Fisgin T, et al. Low protein Z levels in children with nephrotic syndrome. Pediatr Nephrol 2006; 21: 1122-1126.
58. Malyszko J, Skrzydlewska E, Malyszko JS, et al. Protein Z, a vitamin K-dependent protein in patients with renal failure. J Thromb Haemost 2003; 1: 195-196.
59. Blyth E, Favaloro EJ, Harris D, et al Protein Z is reduced in chronic kidney disease and not elevated in patients on haemodialysis. Blood Coagul Fibrinolysis 2008; 19: 23-25.
60. Usalan C, Erdem Y, Altun B, et al. Protein Z levels in haemodialysis patients. Int Urol Nephrol 1999; 31: 541-545.
61. Bek K, Ozkaya O, Fişgin T, et al. Protein Z and natural anticoagulants in children on peritoneal dialysis and hemodialysis. Pediatr Nephrol 2007; 22: 881-886.
62. Del Vecchio GC, Nigro A, Giordano P, et al. Plasma protein Z and protein C inhibitors and their role in hypercoagulability of thalassemia. Acta Haematol 2007; 118: 136-140.
63. Shang Y, Pan XY, Ding CP, et al. Clinical significance of protein Z detection in patients with malignant tumors. Ai Zheng 2005; 24: 1144-1147.
64. Kemkes-Matthes B, Matthes KJ. Protein Z deficiency: a new cause of bleeding tendency. Thromb Res 1995; 79: 49-55.
65. Gamba G, Bertolino G, Montani N, et al. Bleeding tendency of unknown origin and protein Z levels. Thromb Res 1998; 90: 291-295.
66. Obach V, Muñoz X, Sala N, et al. Intronic c.573 + 79G>A polymorphism of protein Z gene in haemorrhagic and ischaemic stroke. Thromb Haemost 2006; 95: 1040-1041.
67. Dahlbäck B. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis. Thromb Haemost 1997; 78: 483-488.
68. Vasse M, Guegan-Massardier E, Borg JY, et al. Frequency of protein Z deficiency in patients with ischaemic stroke Lancet 2001; 357: 933-934.
69. Martinelli I, Razzari C, Biguzzi E, et al. Low levels of protein Z and the risk of venous thromboembolism. J Thromb Haemost 2005; 3: 2817-2819.
70. Kemkes-Matthes B, Nees M, K̈hnel G, et al. Protein Z influences the prothrombotic phenotype in Factor V Leiden patients. Thromb Res 2002; 106: 183-185.
71. Ayoub N, Esposito G, Barete S, et al. Protein Z deficiency in antiphospholipid-negative Sneddon's syndrome. Stroke 2004; 35: 1329-1332.
72. Lopaciuk S, Bykowska K, Kwiecinski H, et al. Protein Z in young survivors of ischemic stroke. Thromb Haemost 2002; 88: 536.
73. Kobelt K, Biasiutti FD, Mattle HP, et al. Protein Z in ischaemic stroke. Br J Haematol 2001; 114: 169-173.
74. Marco P, Marín F, García A, et al. Do protein Z levels influence the prothrombotic state in atrial fibrillation? Thromb Res 2002; 106: 269-270.
75. Sofi F, Cesari F, Vigiani S, et al. Protein Z plasma levels in different phases of activity of coronary atherosclerosis. J Thromb Haemost 2005; 3: 2254-2258.
76. Sofi F, Cesari F, Marcucci R, et al. Protein Z levels and prognosis in patients with acute coronary syndromes. Clin Chem Lab Med 2006; 44: 1098-1102.
77. Cesari F, Fatini C, Sticchi E, et al. Protein Z gene polymorphisms (intron F 79 G>A; -13 A>G) are not associated with acute coronary syndromes. Thromb Haemost 2006; 96: 98-99.
78. Morange PE, Juhan-Vague I; PRIME Study Group. Protein Z plasma levels are not associated with the risk of coronary heart disease: the PRIME Study. J Thromb Haemost 2004; 2: 2050-2051.
79. Sofi F, Cesari F, Pratesi G, et al. Low protein Z levels in patients with peripheral arterial disease. Thromb Haemost 2007; 98: 1114-1117.
80. Pardos-Gea J, Ordi-Ros J, Serrano S, et al. Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis. Thromb Res 2007; doi:10.1016/j.thromres.2007.07.009
81. Koren-Michowitz M, Eting E, Rahimi-Levene N, et al. Protein Z levels and central retinal vein or artery occlusion. Eur J Haematol 2005; 75: 401-405.
82. Oztürk MA, Ozbalkan Z, Onat AM, et al. Decreased protein Z concentrations complicating the hypercoagulable state of Behçet's disease. Clin Appl Thromb Hemost 2003; 9: 259-263.
83. Koutroubakis IE, Theodoropoulou A, Sfiridaki A, et al. Low plasma protein Z levels in patients with ischemic colitis. Dig Dis Sci 2003; 48: 1673-1676.
84. McColl MD, Deans A, Maclean P, et al. Plasma protein Z deficiency is common in women with antiphospholipid antibodies. Br J Haematol 2003; 120: 913-914.
85. Forastiero RR, Martinuzzo ME, Lu L, et al. Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor. J Thromb Haemost 2003; 1: 1764-1770.
86. Gris JC, Amadio C, Mercier E, et al. Anti-protein Z antibodies in women with pathologic pregnancies. Blood 2003; 101: 4850-4852.
87. Sailer T, Vormittag R, Koder S, et al. Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant. Thromb Res 2007; doi:10.1016/j.thromres.2007.07.014.
88. Gris JC, Quéré I, Dechaud H, et al. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002; 99: 2606-2608.
89. Gris JC, Mercier E, Quéré I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004; 103: 3695-3699.
90. Erez O, Hoppensteadt D, Romero R, et al. Pre-eclampsia is associated with low concentrations of protein Z. J Matern Fetal Neonatal Med 2007; 20: 661-667.
91. Grandone E, Colaizzo D, Cappucci F, et al. Protein Z levels and unexplained fetal losses. Fertil Steril 2004; 82: 982-983.
92. Dossenbach-Glaninger A, van Trotsenburg M, Helmer H, et al. Association of the protein Z intron F G79A gene polymorphism with recurrent pregnancy loss. Fertil Steril 2008; doi:10.1016/fertnstert.2007.07.1376.
93. Greten J, Kreis I, Liliensiek B, et al. Localisation of protein Z in vascular lesions of patients with atherosclerosis. Vasa 1998; 27: 144-148.
94. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85: e17-24.
95. Uyemura K, Demer LL, Castle SC, et al. Cross-regulatory roles of interleukin (IL-)12 and IL-10 in atherosclerosis. J Clin Invest 1996; 97: 2130-2138.
96. Herbert J, Bono F, Herault J et al. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. Clin Invest 1998; 101: 993-1000.
97. Ragosta M, Gimple LW, Gertz SD et al. Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1994; 89: 1262-1271.
98. Frère C, Morange PE, Saut N, et al. Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact. Thromb Haemost 2005; 94: 373-379.